Home
Highbridge Capital Management reported a 4.2% stake in OnKure Therapeutics OKUR · 542,361 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.2%
- Last report
- 5.2% · filed 25/08/14
- Shares held
- 542,361 sh
- Class
- Class A Common Stock, par value $0.0001 per share
- Event date
- 25/12/31
- Filed
- 26/02/17
4.2% stake · below 5%
- Stake
- 4.2%
- Last report
- 5.2%
- Since last report
- −1.0pp
OnKure Therapeutics trades, last 26 weeks
What else happened in OnKure Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Highbridge Capital Management's other 5% stake reports
- Highbridge Capital Management
5% stakeDisciplined Growth Acquisition
5% stakeDisciplined Growth Acquisition
DGAC
8.5% stake
1,421,616 sh
8.5% stake
Filed 08/14
- Highbridge Capital Management
5% stakeCrown Reserve Acquisition Corp. I
5% stakeCrown Reserve Acquisition Corp. I
CRAC
9.1% stake
1,637,592 sh
9.1% stake
Filed 08/14
- Highbridge Capital Management
5% stakeAxiom Intelligence Acquisition Corp 1
5% stakeAxiom Intelligence Acquisition Corp 1
AXIN
9.1% stake
1,870,276 sh
9.1% stake
Filed 08/14
- Highbridge Capital Management
5% stakeARC Group Acquisition I
5% stakeARC Group Acquisition I
ARCL
9% stake
1,146,244 sh
9% stake
Filed 08/14
- Highbridge Capital Management
5% stakeAnnovis Bio
5% stakeAnnovis Bio
ANVS
6.1% stake
2,775,578 sh
6.1% stake
Filed 08/14
